Additional markers of risk for diabetic microvascular complications beyond Hemoglobin A1c needed The ‘gold standard’ diabetes test, Hemoglobin A1c , explains significantly less about the chance of cardiovascular complications in patients with diabetes than originally thought, according to articles in the June 9 issue of the Journal of the American Medical Association here .D., of the University of Washington Medical School and Michael Brownlee, M.D., of the Albert Einstein University of Medicine . The authors contend that the A1C ensure that you duration of diabetes explain only 11 percent of the risk of microvascular problems in the Diabetes Control and Problems Trial , a major landmark study in diabetes care.S.
These levels also were very similar to those reported in the two pivotal testosterone patch research which showed efficacy in treating HSDD in estrogen-treated surgically menopausal ladies, that have been 4.0 pg/ml at 12 weeks and 3.1 pg/ml at week 24 and 4.0 pg/ml at week 24, respectively. In a recently available publication, it was shown that serum testosterone concentrations in normally cycling 30-year-old pre-menopausal ladies range from 1.2 pg/ml to 6.4 pg/ml. However, generally, blood levels are not compared between studies because different studies performed at differing times with different assays can generate varying testosterone blood amounts.